Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02727270 · ClinicalTrials.gov registry record
Measuring Cortisol Levels in Persons With Parkinson's (PD)
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 131
- Enrollment target
NCT02727270: Completed study, sponsored by Oregon Health and Science University.
NCT02727270 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 131 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02727270 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 131 participants
- Enrollment target
Study Summary
The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and controls.
Primary Outcome
Salivary Cortisol level (ug/dL) Response is the change in cortisol between awakening and 30 minutes after awakening.
Interventions
- OTHER No Intervention - Observational Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2016-06 |
| Est. Completion | 2023-11-16 |
What the finished NCT02727270 record still lists
NCT02727270 is an observational study that tracks outcomes without assigning an intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which No Intervention - Observational Study is the first listed.
NCT02727270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02727270 about?
NCT02727270 is a clinical study titled "Measuring Cortisol Levels in Persons With Parkinson's (PD)". The objective of this study is to evaluate the cortisol awakening response with persons with Parkinsons Disease (PD), Huntingtons Disease (HD), and controls. These data are desired so experience can be gained with measuring stress levels subjectively and objectively in persons with PD, HD, and contr...
What is the current status of trial NCT02727270?
This trial is currently completed. The enrollment target is 131 participants. The study started on 2016-06. Estimated completion is 2023-11-16.
What interventions are being tested in trial NCT02727270?
The interventions under investigation include: No Intervention - Observational Study (OTHER).
Who is sponsoring clinical trial NCT02727270?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia